Results 11 to 20 of about 3,627,754 (377)

Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents [PDF]

Frontiers in Immunology
Pemphigus foliaceus (PF) is a superficial form of pemphigus. Treatment options for PF resemble pemphigus vulgaris, including glucocorticosteroids, immunosuppressive agents and rituximab et al.
Quanhong Zhang, Quanhong Zhang, Lang Yu, Lang Yu, Li Wan, Liuqing Chen, Liuqing Chen, Jinbo Chen, Jinbo Chen   +8 more
doaj   +2 more sources

COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic. [PDF]

J Cosmet Dermatol, 2022
Aryanian Z, Balighi K, Afshar ZM, Zamanian MH, Razavi Z, Hatami P.   +5 more
europepmc   +3 more sources

The relationship between cumulative dose of immunosuppressive agents and COVID-19-associated mucormycosis: A multicenter cross-sectional study. [PDF]

Health Sci Rep, 2022
Rastkar M, SeyedAlinaghi S, Asanjarani B, Siri G, Abdollahi H, Ghadami L, Hasibi M, Khodashahi R, Bagheri A, Asadollahi-Amin A.   +9 more
europepmc   +3 more sources

Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients. [PDF]

Expert Opin Drug Metab Toxicol, 2021
Job KM, Roberts JK, Enioutina EY, Illamola SM, Kumar SS, Rashid J, Ward RM, Fukuda T, Sherbotie J, Sherwin CM.   +9 more
europepmc   +3 more sources

Metabolic consequences of modern immunosuppressive agents in solid organ transplantation [PDF]

Therapeutic Advances in Endocrinology and Metabolism, 2016
O. Bamgbola
semanticscholar   +2 more sources

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis. [PDF]

Front Pharmacol, 2022
Liu J, Li X, Huang T, Xu G.
europepmc   +2 more sources

Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? [PDF]

Cancer Cell Int
Anvar MT, Rashidan K, Arsam N, Rasouli-Saravani A, Yadegari H, Ahmadi A, Asgari Z, Vanan AG, Ghorbaninezhad F, Tahmasebi S.   +9 more
europepmc   +3 more sources

Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review. [PDF]

PLoS Negl Trop Dis, 2022
Durieux MF, Lopez JG, Banjari M, Passebosc-Faure K, Brenier-Pinchart MP, Paris L, Gargala G, Berthier S, Bonhomme J, Chemla C, Villena I, Flori P, Fréalle E, L'Ollivier C, Lussac-Sorton F, Montoya JG, Cateau E, Pomares C, Simon L, Quinio D, Robert-Gangneux F, Yera H, Labriffe M, Fauchais AL, Dardé ML.   +24 more
europepmc   +3 more sources

Microsponge-derived mini tablets loaded with immunosuppressive agents: Pharmacokinetic investigation in human volunteers, cell viability and IVIVC correlation. [PDF]

Saudi Pharm J, 2023
Mehmood Y, Shahid H, Abbas M, Farooq U, Farooq U, Ali S, Kazi M.   +6 more
europepmc   +2 more sources

Immunosuppressive agents in diabetes treatment: Hope or despair? [PDF]

World J Diabetes
Lu Li, Xi Yang, Jindong Ren, Mingzhu Huang, Qingwei Zhao   +4 more
europepmc   +2 more sources